TRINITY ASSETS CO., Ltd (TAC). is a privately-owned Thai company engaged in various business activities. One major project of TAC is to support the clinical trial of REMUNE® in Thailand by: - Setting up a data center and facilities to manage the distribution of REMUNE® in Thailand;
- Managing and overseeing a “Research Center for HIV/AIDS Treatment”;
- Sponsor further studies of REMUNE® as mono-immune-based therapy and in combination with other drugs and nutritional supplements for HIV+ volunteers in varying stages of illness or different levels of CD4+ cells; and
- Working to register HIV-1 Immunogen (REMUNE®) in Thailand.
(REMUNE® is manufactured by The Immune Response Corporation of Carlsbad, California, USA) Updated on November 15, 2004 | 
